Reported Tuberculosis in the United States, 2017
Table 16. National Tuberculosis Genotyping Surveillance Coverage1 : United States, 2004-2017
Year | Reported TB Cases | Reported Culture-Positive Cases | Cases with Genotype Results | Genotype Surveillance Coverage |
---|---|---|---|---|
No. | No. | No. | (%) | |
2004 | 14,499 | 11,327 | 5,954 | 52.6 |
2005 | 14,065 | 10,957 | 7,500 | 68.4 |
2006 | 13,727 | 10,744 | 7,528 | 70.1 |
2007 | 13,280 | 10,425 | 8,428 | 80.8 |
2008 | 12,889 | 10,020 | 8,177 | 81.6 |
2009 | 11,514 | 8,880 | 7,715 | 86.9 |
2010 | 11,100 | 8,412 | 7,704 | 91.6 |
2011 | 10,504 | 8,084 | 7,617 | 94.2 |
2012 | 9,935 | 7,626 | 7,235 | 94.9 |
2013 | 9,561 | 7,368 | 7,063 | 95.9 |
2014 | 9,398 | 7,232 | 6,991 | 96.7 |
2015 | 9,547 | 7,418 | 7,206 | 97.1 |
2016 | 9,253 | 7,171 | 6,986 | 97.4 |
2017 | 9,105 | 7,111 | 6,851 | 96.3 |
1 Genotype surveillance coverage is defined as the percentage of all culture positive tuberculosis (TB) cases for which there was a genotyped isolate.
Note: This table reflects genotyping surveillance coverage for the 50 states and the District of Columbia; for genotyping surveillance coverage of the U.S.-affiliated areas, please see Table 17.